A Simple Method For Teaching About Voiding Disorders (PDF)
Patients with LUT disorders seek care from a wide range of healthcare providers, including nurses, geriatricians, gynaecologists, urologists, rehabilitation medicine specialists, family physicians and internists, and the collective annual cost of managing them exceeds US$36 billion [1–3].

BJUI Mini Reviews 2006 February

Selecting Therapy For Maintaining Sexual Function In Patients With Benign Prostatic Hyperplasia (PDF)
In patients with BPH, LUTS can diminish quality of life (QoL) by interfering with sexual function [1-3], which has been shown to be an important component of QoL among men even in their later years [4,5].

BJUI Mini Reviews 2005 August

An Evidence-based Approach to Understanding the Pharmacological Class Effect in the Management of Prostatic Diseases (PDF)
Ever more alternative products are available for each drug type commonly used to treat prostatic diseases, i.e. α-blockers, 5α-reductase inhibitors, antiandrogens and LHRH agonists.

BJUI Mini Reviews 2005 April

The Importance of Patient Perception in the Clinical Assessment of Benign Prostatic Hyperplasia and its Management (PDF)
BPH is a common disorder of ageing men, occurring in 19-30% of men aged > 50 years [1,2], and is therefore a significant contributor to the daily practice of urologists and primary-care physicians.

BJUI Mini Reviews 2005 January

Optimising the Medical Management of Benign Prostatic Hyperplasia
As demographics change, with the elderly constituting an increasing proportion of the population, the prevalence of benign prostatic hyperplasia (BPH) is increasing, with a resultant impact on medical practice.

2004-04-12

Please log-in or register in order to submit comments.

Powered by AkoComment!